Why Zambians don't test and treat
Keeping children in school shows impact on HIV risk behaviours in Kenya
South African study finds most women disclose HIV status to family, but far fewer to sexual partners
Dramatic increases in life expectancy in a high-burden HIV setting due to ARV rollout
Population viral load decreases in 'test and treat' study in Uganda
Studies highlight complex questions about how communities will respond to PrEP
Novel TB combination regimen shows potent activity in randomised short-term clinical trial
Once-daily maraviroc plus boosted atazanavir promising at 96 weeks
The paradox of HIV in black MSM in the US – very high infection rates despite no more risky sex and more precautions
International AIDS Conference hears how drugs, sex and HIV interlock
Adolescent antiretroviral options expanding
New antiretrovirals for infants and children still needed
Uganda field study finds that HIV treatment has not reduced new infections in couples
Hillary Clinton pledges money for vulnerable minorities, reproductive rights, AIDS-free families
'Global health charge' on alcohol and tobacco could cover HIV drug costs in 10 countries
Co-administration of rifampicin and efavirenz does not reduce efavirenz concentrations or efficacy
UNITAID commits US$140 million to bring HIV diagnostic technologies to the ‘point of care’
They say we can “end AIDS”, but who will pay for it?
